(January 17, 2012) -- After a two-year investigation, the FTC has settled its deceptive pricing investigation with CVS Caremark Corp. The company will pay $5 million to settle charges that it misrepresented the prices of certain Medicare Part D prescription drugs at CVS and Walgreens pharmacies. In return, the FTC has closed its investigation....